Skip to content

Characterising and Tracking of Patients with Inherited Neurodegenerative Disorders (INDD)

A longitudinal natural history study characterising and tracking of patients with Inherited Neurodegenerative Disorders (INDD)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12624000381583
Enrollment
10
Registered
2024-04-02
Start date
2024-08-28
Completion date
2029-02-01
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project seeks to undertake a prospective longitudinal natural history study to generate a comprehensive phenotypic profile of biological, behavioural, clinical, neurocognitive and neurophysiological markers associated with INDD and its progression; and correlate with the genotype when clinically available. This work will provide more complete neurobiological descriptions, novel mechanistic insights, and clear recommendations regarding candidate biomarkers for diagnosis and treatment tracking.

Interventions

Neurodegenerative disorders cause a collapse of the structure and function of neural networks. In this study sensory, motor, autonomic and cognitive functions are observed. The non-invasive neurological (gait and balance assessments), cognitive (tests for processing speed, attention and working memory), swallowing (a clinical assessment of dysphagia) vestibular (assessment of inner ear balance by observing eye movements) and Nerve Excitability Study (tests conductivity and electrical activity o

Neurodegenerative disorders cause a collapse of the structure and function of neural networks. In this study sensory, motor, autonomic and cognitive functions are observed. The non-invasive neurological (gait and balance assessments), cognitive (tests for processing speed, attention and working memory), swallowing (a clinical assessment of dysphagia) vestibular (assessment of inner ear balance by observing eye movements) and Nerve Excitability Study (tests conductivity and electrical activity of the nerves) will be administered by suitably trained members of the research team. Observation occurs at Baseline, 3 months, 6 months and 12 months in Year 1, then yearly onwards until the participant has impaired capacity to personally provided informed consent at interim study visits or withdraws from study. Neurological, cognitive, swallowing and vestibular assessments and a nerve excitability study will take approximately 4 hours (with breaks) on site at St Vincent's Hospital at baseline and yearly afterwards." and "Questionnaires, psychomotor and speech assessments using web based tools will take approximately 45 mins at participants home

Sponsors

St Vincent's Health Network
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patient participants Adult patients aged greater than or equal to 18 years with a clinical diagnosis of INDD regardless of prior genetic testing results Adult patients aged greater than or equal to 18 years who are genotype positive but clinically unaffected at time of enrolment Capacity to personally consent Understands spoken and written English Ability to travel to research site Computer literate and access to a computer/tablet/smart phone Healthy control participant A spouse/friend aged greater than or equal to 18 years, of those consenting patient participants who: Has capacity to personally consent Understands spoken and written English Has ability to travel to research site Computer literate and access to a computer/tablet/smart phone

Exclusion criteria

None

Outcome results

None listed

Source: ANZCTR · Data processed: May 7, 2026